Merck

Merck CEO Ken Frazier Is Looking Smart For Avoiding A Tax Inversion
Forbes
Wed, 04/6/16 - 09:49 am
Merck
Ken Frazier
Pfizer
Allergan
tax inversions
Patent Palooza: One Patent Battle in Hep C, And Another Patent Brawl Brewing On Capitol Hill
Motley Fool
Mon, 04/4/16 - 07:59 am
patents
hepatitis C
Medivation
Xtandi
Merck
Ionis Pharmaceuticals
Gilead Sciences
Bristol-Myers Squibb Is Crushing Its Competition In The Cancer Treatment Market
Seeking Alpha
Mon, 04/4/16 - 07:57 am
Bristol-Myers Squibb
cancer
oncology
Merck
Opdivo
How Big of a Deal Are Gilead Sciences Patent Woes?
Motley Fool
Fri, 04/1/16 - 10:04 pm
Gilead Sciences
patents
Merck
Ionis Pharmaceuticals
hepatitis C
Biogen's Newer Problems; Their Relevance To The Biotech Sector
Seeking Alpha
Mon, 03/28/16 - 09:22 pm
Biogen
Tecfidera
Merck
Ionis Pharmaceuticals
Gilead Sciences
Amgen
Regeneron
Gilead Sciences: ‘Another Pretender to Hepatitis C Throne Seems to Be Suffering the AbbVie Fate’
Barron's
Mon, 03/28/16 - 11:32 am
Gilead Sciences
hepatitis C
Merck
Zepatier
Harvoni
Patent Payoff? Merck's and Ionis Pharmaceuticals' Take Could Be Tiny
Motley Fool
Sat, 03/26/16 - 01:04 pm
Merck
Gilead Sciences
Ionis Pharmaceuticals
hepatitis C
patents
Harvoni
Sovaldi
Gilead to Pay Merck $200 Million in Damages Over Hepatitis C Drug Patents
WSJ Online
Fri, 03/25/16 - 09:42 am
Gilead Sciences
Harvoni
Sovaldi
hepatitis C
Merck
Impact Of Merck Litigation On Ionis Pharmaceuticals
Seeking Alpha
Thu, 03/24/16 - 09:47 am
Ionis Pharmaceuticals
Merck
Gilead Sciences
patents
hepatitis C
Gilead's CEO: We are appealing the case
CNBC
Thu, 03/24/16 - 09:29 am
Gilead Sciences
patents
Merck
John Milligan
Harvoni
Sovaldi
hepatitis C
Merck enlists patients for award-winning marketing on black box allergy-fighters Ragwitek, Grastek
Fierce Pharma Marketing
Wed, 03/23/16 - 09:27 pm
Merck
Ragwitek
Grastek
hay fever
Gilead, Biogen Troubles Remind Investors Why Strong Drug Patents Are Vital
TheStreet.com
Wed, 03/23/16 - 09:24 pm
Gilead Sciences
Biogen
patents
Merck
Kyle Bass
Amgen
Regeneron
Sanofi
Gilead May Have to Pay Rival Merck Billions in Royalties
Fortune
Wed, 03/23/16 - 04:04 pm
Gilead Sciences
Merck
patents
sofosbuvir
Harvoni
Sovaldi
hepatitis C
Merck wins major victory in hep C patent case against Gilead
BioPharma Dive
Wed, 03/23/16 - 09:45 am
Merck
hepatitis C
patents
Gilead Sciences
sofosbuvir
Harvoni
Sovaldi
Switching study gives Celltrion biosim more ammo in fight for Remicade share
Fierce Pharma Marketing
Tue, 03/22/16 - 09:54 am
Celltrion
biosimilars
Merck
Remicade
Remsima
Merck's $20M-plus Harvard deal offers a lesson on the new Economics 101 of preclinical R&D
Fierce Biotech
Mon, 03/21/16 - 09:10 am
Merck
Harvard
R&D
Gilead And The $3 Billion Merck Issue
Seeking Alpha
Fri, 03/18/16 - 11:10 am
Gilead Sciences
Merck
patents
hepatitis C
Harvoni
Sovaldi
The 5 Highest Paid Executives in the Healthcare Sector
Investopedia
Fri, 03/18/16 - 10:35 am
executive pay
Allergan
Brent Saunders
Merck
Kenneth Frazier
JNJ
Alex Gorsky
Pfizer
Ian Read
Cholesterol pill boosts cancer immunotherapy, at least in mice
Yahoo/Reuters
Thu, 03/17/16 - 05:03 pm
Opdivo
Keytruda
Avasimibe
Merck
Bristol-Myers Squibb
cancer immunotherapy
Pfizer
Merck's Keytruda held back by docs who don't want to wait for diagnostics
Fierce Pharma Marketing
Mon, 03/14/16 - 05:59 pm
Merck
Keytruda
physicians
Opdivo
Bristol-Myers Squibb

Pages